Top Clinical Trials companies in Hong Kong by Operating Income Margin
Hong Kong
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
7.78%
|
Dec. 31, 2023 | USD 0.21 | -2.41% |
|
Hong Kong |
|
| 2 |
3.42%
|
Dec. 31, 2023 | USD 0.16 | 4.01% |
|
Hong Kong |
|
| 3 |
2.19%
|
Dec. 31, 2023 | USD 2.63 | -1.97% |
|
Hong Kong |
|
| 4 |
-238.73%
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
| 5 |
-19,432.24%
|
Dec. 31, 2023 | USD 0.36 | -3.86% |
|
Hong Kong |
Frequently Asked Questions
-
Which Clinical Trials company in Hong Kong has the highest Operating Income Margin ?
The Clinical Trials company in Hong Kong with the highest Operating Income Margin is Frontage Holdings Corporation (HKSE: 1521.HK) at 7.78%.
-
Which Clinical Trials company in Hong Kong has the lowest Operating Income Margin ?
The Clinical Trials company in Hong Kong with the lowest Operating Income Margin is Sirnaomics Ltd. (HKSE: 2257.HK) at -19,432.24%.
-
What are the top 10 Clinical Trials companies in Hong Kong by Operating Income Margin ?
The top 10 Clinical Trials companies in Hong Kong by Operating Income Margin are Frontage Holdings Corporation, Lee's Pharmaceutical Holdings Limited, HUTCHMED (China) Limited, Prenetics Global Limited and Sirnaomics Ltd..
-
What are the bottom 10 Clinical Trials companies in Hong Kong by Operating Income Margin ?
The bottom 10 Clinical Trials companies in Hong Kong by Operating Income Margin are Sirnaomics Ltd., Prenetics Global Limited, HUTCHMED (China) Limited, Lee's Pharmaceutical Holdings Limited and Frontage Holdings Corporation.
